• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ANGPTL4 T266M 变异与降低癌症侵袭性有关。

ANGPTL4 T266M variant is associated with reduced cancer invasiveness.

机构信息

School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore.

School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore.

出版信息

Biochim Biophys Acta Mol Cell Res. 2017 Oct;1864(10):1525-1536. doi: 10.1016/j.bbamcr.2017.06.010. Epub 2017 Jun 19.

DOI:10.1016/j.bbamcr.2017.06.010
PMID:28641978
Abstract

Angiopoietin-like 4 (ANGPTL4) is a secretory protein that can be cleaved to form an N-terminal and a C-terminal protein. Studies performed thus far have linked ANGPTL4 to several cancer-related and metabolic processes. Notably, several point mutations in the C-terminal ANGPTL4 (cANGPTL4) have been reported, although no studies have been performed that ascribed these mutations to cancer-related and metabolic processes. In this study, we compared the characteristics of tumors with and without wild-type (wt) cANGPTL4 and tumors with cANGPTL4 bearing the T266M mutation (T266M cANGPTL4). We found that T266M cANGPTL4 bound to integrin α5β1 with a reduced affinity compared to wt, leading to weaker activation of downstream signaling molecules. The mutant tumors exhibited impaired proliferation, anoikis resistance, and migratory capability and had reduced adenylate energy charge. Further investigations also revealed that cANGPTL4 regulated the expression of Glut2. These findings may explain the differences in the tumor characteristics and energy metabolism observed with the cANGPTL4 T266M mutation compared to tumors without the mutation.

摘要

血管生成素样蛋白 4(ANGPTL4)是一种分泌蛋白,可被切割形成 N 端和 C 端蛋白。迄今为止的研究将 ANGPTL4 与几种与癌症相关的代谢过程联系起来。值得注意的是,已经报道了 C 端 ANGPTL4(cANGPTL4)中的几个点突变,尽管尚未进行将这些突变归因于与癌症相关的代谢过程的研究。在这项研究中,我们比较了具有野生型(wt)cANGPTL4 的肿瘤和没有 cANGPTL4 的肿瘤的特征,以及具有 T266M 突变的 cANGPTL4(T266M cANGPTL4)的肿瘤。我们发现,与 wt 相比,T266M cANGPTL4 与整合素 α5β1 的结合亲和力降低,导致下游信号分子的激活减弱。突变型肿瘤表现出增殖受损、抗失巢凋亡能力和迁移能力降低,以及腺嘌呤核苷酸能量电荷降低。进一步的研究还表明,cANGPTL4 调节 Glut2 的表达。这些发现可以解释与突变型肿瘤相比,cANGPTL4 T266M 突变型肿瘤的肿瘤特征和能量代谢的差异。

相似文献

1
ANGPTL4 T266M variant is associated with reduced cancer invasiveness.ANGPTL4 T266M 变异与降低癌症侵袭性有关。
Biochim Biophys Acta Mol Cell Res. 2017 Oct;1864(10):1525-1536. doi: 10.1016/j.bbamcr.2017.06.010. Epub 2017 Jun 19.
2
ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters.ANGPTL4 通过整合素信号调节血管连接完整性,并破坏细胞间 VE-钙黏蛋白和 Claudin-5 簇。
Blood. 2011 Oct 6;118(14):3990-4002. doi: 10.1182/blood-2011-01-328716. Epub 2011 Aug 12.
3
Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.肿瘤组织中双重作用信号介质 ANGPTL4 的表观遗传沉默及其在尿路上皮癌微环境中的过表达。
Oncogene. 2018 Feb 1;37(5):673-686. doi: 10.1038/onc.2017.375. Epub 2017 Oct 16.
4
Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines.缺氧诱导的 ANGPTL4 通过不同机制在弥漫型胃癌细胞系中维持肿瘤生长和抗失巢凋亡。
Sci Rep. 2017 Sep 11;7(1):11127. doi: 10.1038/s41598-017-11769-x.
5
Knockdown of angiopoietin-like 4 inhibits the development of human gastric cancer.敲低血管生成素样蛋白 4 抑制人胃癌的发展。
Oncol Rep. 2018 Apr;39(4):1739-1746. doi: 10.3892/or.2018.6253. Epub 2018 Feb 7.
6
Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial-mesenchymal transition by inducing 14-3-3γ expression.血管生成素样蛋白4提高腺苷酸能荷通过诱导14-3-3γ表达增强上皮-间质转化。
Oncogene. 2017 Nov 16;36(46):6408-6419. doi: 10.1038/onc.2017.244. Epub 2017 Jul 24.
7
LMX1A inhibits C-Myc expression through ANGPTL4 to exert tumor suppressive role in gastric cancer.LMX1A 通过 ANGPTL4 抑制 C-Myc 表达,从而在胃癌中发挥肿瘤抑制作用。
PLoS One. 2019 Sep 26;14(9):e0221640. doi: 10.1371/journal.pone.0221640. eCollection 2019.
8
T266M variants of ANGPTL4 improve lipid metabolism by modifying their binding affinity to acetyl-CoA carboxylase in obstructive sleep apnea.ANGPTL4的T266M变体通过改变其在阻塞性睡眠呼吸暂停中与乙酰辅酶A羧化酶的结合亲和力来改善脂质代谢。
Ann Med. 2024 Dec;56(1):2337740. doi: 10.1080/07853890.2024.2337740. Epub 2024 Apr 4.
9
Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer.血管生成素样4纤维蛋白原样结构域(cANGPTL4)的表达增加了乳腺癌女性发生脑转移的风险。
Oncotarget. 2020 May 5;11(18):1590-1602. doi: 10.18632/oncotarget.27553.
10
ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.血管生成素样蛋白4与非小细胞肺癌进展相关,并通过ERK途径调节上皮-间质转化。
Lung. 2016 Aug;194(4):637-46. doi: 10.1007/s00408-016-9895-y. Epub 2016 May 11.

引用本文的文献

1
Recent Advancements in Understanding the Role and Mechanisms of Angiopoietin-like Proteins in Diabetic Retinopathy.血管生成素样蛋白在糖尿病视网膜病变中的作用及机制研究的最新进展
Metabolites. 2025 May 26;15(6):352. doi: 10.3390/metabo15060352.
2
ANGPTL4-the Link Binding Lipid Metabolism and Inflammation.血管生成素样蛋白4——脂质代谢与炎症的联系纽带
Curr Med Chem. 2025;32(15):2931-2949. doi: 10.2174/0109298673320024240829070906.
3
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance.ANGPTL4 是 HCV 诱导外周胰岛素抵抗的潜在驱动因素。
Sci Rep. 2023 Apr 25;13(1):6767. doi: 10.1038/s41598-023-33728-5.
4
Angiopoietin-like 4 induces head and neck squamous cell carcinoma cell migration through the NRP1/ABL1/PXN pathway.血管生成素样蛋白 4 通过 NRP1/ABL1/PXN 通路诱导头颈部鳞状细胞癌细胞迁移。
Cell Signal. 2023 Aug;108:110697. doi: 10.1016/j.cellsig.2023.110697. Epub 2023 May 9.
5
Oleic acid-induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis.油酸诱导的 NOX4 依赖于 ANGPTL4 的表达来促进人结直肠癌转移。
Theranostics. 2020 May 30;10(16):7083-7099. doi: 10.7150/thno.44744. eCollection 2020.
6
Mining the role of angiopoietin-like protein family in gastric cancer and seeking potential therapeutic targets by integrative bioinformatics analysis.通过综合生物信息学分析挖掘血管生成素样蛋白家族在胃癌中的作用并寻找潜在的治疗靶点。
Cancer Med. 2020 Jul;9(13):4850-4863. doi: 10.1002/cam4.3100. Epub 2020 May 14.
7
Alteration of Angiopoietin-Like Protein 4 Levels in Serum or Urine Correlate with Different Biochemical Markers in Hyperlipidemia-Related Proteinuria.血清或尿液中血管生成素样蛋白 4 水平的改变与高脂血症相关性蛋白尿中的不同生化标志物相关。
Biomed Res Int. 2020 Mar 23;2020:5281251. doi: 10.1155/2020/5281251. eCollection 2020.
8
Angiopoietin-like 4 deficiency upregulates macrophage function through the dysregulation of cell-intrinsic fatty acid metabolism.血管生成素样蛋白4缺乏通过细胞内源性脂肪酸代谢失调上调巨噬细胞功能。
Am J Cancer Res. 2020 Feb 1;10(2):595-609. eCollection 2020.
9
Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs.通过靶向血管生成素样蛋白 4 蛋白来提高代谢灵活性可使转移性癌细胞对化疗药物更敏感。
Mol Cancer. 2018 Oct 20;17(1):152. doi: 10.1186/s12943-018-0904-z.
10
A review of the multifunctionality of angiopoietin-like 4 in eye disease.血管生成素样蛋白 4 在眼部疾病中的多功能性研究综述。
Biosci Rep. 2018 Sep 13;38(5). doi: 10.1042/BSR20180557. Print 2018 Oct 31.